Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAptose to Present at 31st Annual Piper Jaffray Healthcare ConferencePREV STORYEuropean Medicines Agency Accepts for Review Marketing Authorization Application for Amarin’s Icosapent Ethyl (Vascepa®) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in REDUCE-IT® Study
